Scynexis (SCYX) Free Cash Flow (2013 - 2026)
Scynexis (SCYX) reported Free Cash Flow of -$8.1 million for Q1 2026, down 8.52% on a YoY basis from -$8.9 million in Q1 2025, and down 144.02% quarter-over-quarter from $18.4 million in Q4 2025.
Scynexis (SCYX) Free Cash Flow (2013 - 2026) Analysis & Trends
Scynexis has reported Free Cash Flow for 14 years, with the latest figure at -$8.1 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 8.52% year-over-year to -$8.1 million; the trailing twelve-month figure through Mar 2026 stood at -$5.9 million (up 78.45% YoY), and the FY2025 full-year result was -$5.3 million, up 78.0% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$8.1 million, down from $18.4 million in the prior quarter.
- The five-year high for Free Cash Flow was $74.4 million in Q2 2023, with the low at -$22.8 million in Q4 2022.
- Historically, Free Cash Flow has averaged -$3.4 million across 5 years, with a median of -$8.1 million in 2026.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 1606.3% — and 2023, when it surged 500.4%.
- Scynexis' Free Cash Flow stood at -$22.8 million in 2022, then jumped by 66.08% to -$7.7 million in 2023, then decreased by 28.08% to -$9.9 million in 2024, then jumped by 285.74% to $18.4 million in 2025, then sank by 144.02% to -$8.1 million in 2026.
- The last three Free Cash Flow figures came in at -$8.1 million (Q1 2026), $18.4 million (Q4 2025), and -$8.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | -8.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.10 Mn |
| Mar 31, 2026 | -8.10 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Dec 31, 2025 | 18.40 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Sep 30, 2025 | -8.72 Mn |
| Jun 30, 2025 | -7.50 Mn |
| Jun 30, 2025 | -7.50 Mn |
| Mar 31, 2025 | -7.47 Mn |
| Mar 31, 2025 | -7.47 Mn |
| Dec 31, 2024 | -9.91 Mn |
| Dec 31, 2024 | -9.91 Mn |
| Sep 30, 2024 | 765,000.00 |
| Sep 30, 2024 | 765,000.00 |
| Jun 30, 2024 | -10.86 Mn |
| Jun 30, 2024 | -10.86 Mn |
| Mar 31, 2024 | -4.01 Mn |
| Mar 31, 2024 | -4.01 Mn |
| Dec 31, 2023 | -7.74 Mn |
| Dec 31, 2023 | -7.74 Mn |